# The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer.

> **NCT05354856** · PHASE4 · TERMINATED · sponsor: **Rigshospitalet, Denmark** · enrollment: 11 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Indocyanine green

## Key facts

- **NCT ID:** NCT05354856
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-03-11
- **Primary completion:** 2023-12-29
- **Final completion:** 2023-12-30
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** recruiting issues
- **Last updated:** 2024-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354856, "The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05354856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*